The importance of the prenyl group in the activities of osthole in enhancing bone formation and inhibiting bone resorption in vitro

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Zhai, Yuan Kun ^a   Pan, Ya Lei ^a   Niu, Yin Bo ^a   Li, Chen Rui ^a   Wu, Xiang Long ^a   Fan, Wu Tu ^a   Lu, Ting Li ^a   Mei, Qi Bing ^a,b   Xian, Cory J ^c  

^a NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

^b Collaborative Innovation Center for Chinese Medicine in Qin Mountains ^*  (China)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; HERNIARIN; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; OSTHOLE; TRANSCRIPTION FACTOR RUNX2;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; BONE DEVELOPMENT; BONE FRAGILITY; BONE MARROW STROMA CELL; BONE METABOLISM; CALVARIA; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COLLAGEN DEGRADATION; COLORIMETRY; CONTROLLED STUDY; DRUG EFFICACY; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; MALE; MICROSCOPY; MINERALIZATION; MORPHOLOGY; NONHUMAN; OPTICAL DENSITY; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

EID: 84928267819     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/921954     Document Type: Article

References (44)

1. J. A. Kanis, "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of aWHO report," Osteoporosis International, vol. 4, no. 6, pp. 368-381, 1994.
2. D. Curran, M. Maravic, P. Kiefer, V. Tochon, and P. Fardellone, "Epidemiology of osteoporosis-related fractures in France: a literature review," Joint Bone Spine, vol. 77, no. 6, pp. 546-551, 2010.
3. Z. Q. Wang, J. L. Li, Y. L. Sun et al., "Chinese herbal medicine for osteoporosis: a systematic review of randomized controlled trails," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 356260, 11 pages, 2013.
4. Y. Mouri, M. Yoshida, S. Nakano et al., "A case of osteonecrosis of the jaw in a breast cancer patient with bone metastases receiving long-term treatment with bisphosphonates," Breast Cancer, vol. 16, no. 2, pp. 147-150, 2009.
5. S. Khosla, J. J. Westendorf, and M. J. Oursler, "Building bone to reverse osteoporosis and repair fractures," Journal of Clinical Investigation, vol. 118, no. 2, pp. 421-428, 2008.
6. P. Wei, M. Liu, Y. Chen, and D. Chen, "Systematic review of soy isoflavone supplements on osteoporosis in women," Asian Pacific Journal of Tropical Medicine, vol. 5, no. 3, pp. 243-248, 2012.
7. Y. K. Zhai, X. Guo, Y. L. Pan, Y. B. Niu C, and Q. B. Mei, "A systematic review of the efficacy and pharmacological profile of Herba Epimedii in osteoporosis therapy," Pharmazie, vol. 68,no. 9, pp. 713-722, 2013.
8. J. Li and W. Chan, "Investigation of the biotransformation of osthole by liquid chromatography/tandem mass spectrometry," Journal of Pharmaceutical and Biomedical Analysis, vol. 74, pp. 156-161, 2013.
9. J. Zhang, J. Xue, H. Wang, Y. Zhang, and M. Xie, "Osthole improves alcohol-induced fatty liver in mice by reduction of hepatic oxidative stress," Phytotherapy Research, vol. 25, no. 5, pp. 638-643, 2011.
10. D. Ding, S. Wei, Y. Song et al., "Osthole exhibits anti-cancer property in rat glioma cells through inhibiting PI3K/Akt and MAPK signaling pathways," Cellular Physiology and Biochemistry, vol. 32, no. 6, pp. 1751-1760, 2013.
11. F. Li, Q. Gong, L. Wang, and J. Shi, "Osthole attenuates focal inflammatory reaction following permanent middle cerebral artery occlusion in rats," Biological and Pharmaceutical Bulletin, vol. 35, no. 10, pp. 1686-1690, 2012.
12. H. J. Liang, F. M. Suk, C. K. Wang et al., "Osthole, a potential antidiabetic agent, alleviates hyperglycemia in db/db mice," Chemico-Biological Interactions, vol. 181, no. 3, pp. 309-315, 2009.
13. X. Chao, J. Zhou, T. Chen et al., "Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats," Brain Research, vol. 1363, pp. 206-211, 2010.
14. J. Bao, M. Xie, and L. Zhu, "Treatment of osthol on osteoporosis in ovariectomized rats," Chinese Pharmacological Bulletin, vol. 27, no. 4, pp. 591-592, 2011.
15. L. G. Ming, J. Zhou, G. Z. Cheng, H. P. Ma, and K. M. Chen, "Osthol, a coumarin isolated from common cnidium fruit, enhances the differentiation and maturation of osteoblasts in vitro," Pharmacology, vol. 88, no. 1-2, pp. 33-43, 2011.
16. L. G.Ming, M. G. Wang, K.M. Chen, J. Zhou, G. Q. Han, and R. Q. Zhu, "Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro," Acta Pharmaceutica Sinica, vol. 47, no. 2, pp. 174-179, 2012.
17. Y. Zhang, X. Li, X. Yao, and M.Wong, "Osteogenic activities of genistein derivatives were influenced by the presence of prenyl group at ring A," Archives of Pharmacal Research, vol. 31, no. 12, pp. 1534-1539, 2008.
18. F. A. Bhat, G. Ramajayam, S. Parameswari et al., "Di 2-ethyl hexyl phthalate affects differentiation and matrix mineralization of rat calvarial osteoblasts-in vitro," Toxicology in Vitro, vol. 27, no. 1, pp. 250-256, 2013.
19. J. Hino, H. Matsuo, and K. Kangawa, "Bone morphogenetic protein-3b (BMP-3b) gene expression is correlated with differentiation in rat calvarial osteoblasts," Biochemical and Biophysical Research Communications, vol. 256, no. 2, pp. 419-424, 1999.
20. J.David, L.Neff,Y.Chen,M.Rincon,W. C.Horne, andR. Baron, "A new method to isolate large numbers of rabbit osteoclasts and osteoclast-like cells: application to the characterization of serum response element binding proteins during osteoclast differentiation," Journal of Bone and Mineral Research, vol. 13, no. 11, pp. 1730-1738, 1998.
21. S. I. Deliloglu-Gurhan, H. S. Vatansever, F. Ozdal-Kurt, and I. Tuglu, "Characterization of osteoblasts derived from bone marrow stromal cells in a modified cell culture system," Acta Histochemica, vol. 108, no. 1, pp. 49-57, 2006.
22. J. Fu, X. Liang, Y. Chen, L. Tang, Q. Zhang, and Q. Dong, "Oxidative stress as a component of chromium-induced cytotoxicity in rat calvarial osteoblasts," Cell Biology and Toxicology, vol. 24, no. 3, pp. 201-212, 2008.
23. H. P. Ma, L. G. Ming, B. F. Ge et al., "Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro," Journal of Cellular Biochemistry, vol. 112, no. 3, pp. 916-923, 2011.
24. A. Giustina, G. Mazziotti, and E. Canalis, "Growth hormone, insulin-like growth factors, and the skeleton," Endocrine Reviews, vol. 29, no. 5, pp. 535-559, 2008.
25. L. Xian, X. Wu, L. Pang et al., "Matrix IGF-1 maintains bone mass by activation ofmTOR inmesenchymal stemcells," Nature Medicine, vol. 18, no. 7, pp. 1095-1101, 2012.
26. T. Komori, "Signaling networks in RUNX2-dependent bone development," Journal of Cellular Biochemistry, vol. 112, no. 3, pp. 750-755, 2011.
27. C. Zhang, "Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx," Journal of Orthopaedic Surgery and Research, vol. 5, no. 1, article 37, pp. 1-7, 2010.
28. J. W. Lee, A. Iwahashi, S. Hasegawa et al., "Coptisine inhibits RANKL-induced NF-B phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells," Journal of Natural Medicines, vol. 66, no. 1, pp. 8-16, 2012.
29. M. C. Kühn, H. S. Willenberg, M. Schott et al., "Adipocytesecreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation," Molecular and Cellular Endocrinology, vol. 349, no. 2, pp. 180-188, 2012.
30. O. Kurt-Sirin, H. Yilmaz-Aydogan, M. Uyar, M. F. Seyhan, T. Isbir, and A. Can, "Combined effects of type I (COL1A1) Sp1 polymorphism and osteoporosis risk factors on mineral density in Turkish postmenopausal women," Gene, vol. 540, no. 2, pp. 226-231, 2014.
31. J. S. Moon, S. H. Oh, Y. W. Jeong et al., "Relaxin augments BMP 2-induced osteoblast differentiation and bone formation," Journal of Bone and Mineral Research, vol. 29, no. 7, pp. 1586-1596, 2014.
32. X.Duan, H. Xu, Y.Wang, H. Wang,G. Li, and L. Jing, "Expression of core-binding factor 1 and osteocalcin influoridetreated fibroblasts and osteoblasts," Journal of Trace Elements in Medicine and Biology, vol. 28, no. 3, pp. 278-283, 2014.
33. Q. Chen, P. Shou, L. Zhang et al., "An osteopontin-integrin interaction plays a critical role in directing adipogenesis and mesenchymal stem cells," Stem Cells, vol. 32, no. 2, pp. 327-337, 2014.
34. K. Harada, H. Itoh, Y. Kawazoe et al., "Polyphosphate-mediated inhibition of acid phosphatase suppression of bone resorption of osteoclasts," PLoS ONE, vol. 8, no. 11, Article ID e78612, 2013.
35. R. Baron and E.Hesse, "Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives," The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 2, pp. 311-325, 2012.
36. M. Hümpel, P. Isaksson, O. Schaefer et al., "Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus," Journal of Steroid Biochemistry and Molecular Biology, vol. 97, no. 3, pp. 299-305, 2005.
37. K. E. Effenberger, S. A. Johnsen, D. G. Monroe, T.C. Spelsberg, and J. J. Westendorf, "Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogens," Journal of Steroid Biochemistry and Molecular Biology, vol. 96, no. 5, pp. 387-399, 2005.
38. M. Rad, M. Hümpel, O. Schaefer et al., "Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women," British Journal of Clinical Pharmacology, vol. 62, no. 3, pp. 288-296, 2006.
39. G. Kretzschmar, O. Zierau, J. Wober, S. Tischer, P. Metz, and G. Vollmer, "Prenylation has a compound specific effect on the estrogenicity of naringenin and genistein," Journal of Steroid Biochemistry and Molecular Biology, vol. 118, no. 1-2, pp. 1-6, 2010.
40. X. X. Li, I. Hara, and T. Matsumiya, "Effects of osthole on postmenopausal osteoporosis using ovariectomized rats; comparison to the effects of estradiol," Biological and Pharmaceutical Bulletin, vol. 25, no. 6, pp. 738-742, 2002.
41. F.Meng, Z. Xiong, Y. Sun, and F. Li, "Coumarins fromCnidium monnieri (L.) and their proliferation stimulating activity on osteoblast-like UMR106 cells," Pharmazie, vol. 59, no. 8, pp. 643-645, 2004.
42. L. G.Ming, X. Lv, X. N.Ma et al., "The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro," Endocrinology, vol. 154, no. 3, pp. 1202-1214, 2013.
43. D. Tang, W. Hou, Q. Zhou et al., "Osthole stimulates osteoblast differentiation and bone formation by activation of -catenin-BMP signaling," Journal of Bone and Mineral Research, vol. 25, no. 6, pp. 1234-1245, 2010.
44. P.-L. Kuo, Y.-L. Hsu, C.-H. Chang, and J.-K. Chang, "Ostholemediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells," Journal of Pharmacology and Experimental Therapeutics, vol. 314, no. 3, pp. 1290-1299, 2005.